Optimizing images of acute deep-vein thrombosis using technetium-99m-apcitide.
The purpose of this paper is to introduce the nuclear medicine technologist to a new radiopharmaceutical, 99mTc-apcitide, for imaging acute venous thrombosis. After reading this paper, the technologist should be able to: (a) describe patient preparation for imaging with 99mTc-apcitide; (b) state the amount of 99mTc-apcitide that is administered to patients for imaging acute venous thrombosis; (c) explain patient positioning for optimal image acquisition; and (d) discuss gamma camera acquisition parameters and their importance in obtaining high-quality images. Clinical cases illustrate both the whole-body distribution and diagnostic value of 99mTc-apcitide in detecting acute deep-vein thrombosis.
Carretta
R F
RF
Sutter-Roseville Medical Center, Roseville, California 95661, USA. rcarretta@aol.com
Streek
P V
PV
Weiland
F L
FL
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007866:Leg / Q000000981:diagnostic imaging; D008297:Male; D015609:Organotechnetium Compounds; D010456:Peptides, Cyclic; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D020246:Venous Thrombosis / Q000000981:diagnostic imaging*
D015609:Organotechnetium Compounds; D010456:Peptides, Cyclic; D019275:Radiopharmaceuticals; C094919:technetium Tc 99m P280